Taek-Chin Cheong

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.
  2019 L1 No data access

1 assessed by us (0 reproduced) · 43 not yet assessed — every PubMed paper on record, linked below.

• Author Correction: Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma ↗

  Nature Medicine · 2026 · PMID 41862708
  not yet assessed
• Abstract 6716: ALK-mRNA vaccine as a new Immunotherapy for ALK+ cancers ↗

  Cancer Research · 2026
  not yet assessed
• APOBEC3 family enzymes induce chromosomal rearrangements by recurrent patterns and enhance the formation of oncogenic fusions in cancers ↗

  Research Square · 2026
  not yet assessed
• EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway ↗

  Cancer Discovery · 2026 · PMID 42329099
  not yet assessed
• Abstract 1509: Discovery of choroid plexus targeted gene therapy to protect cancer chemotherapy-related cognitive impairment ↗

  Cancer Research · 2025
  not yet assessed
• Abstract 2847: Patterns of APOBEC3-mediated chromosomal rearrangements in solid cancers ↗

  Cancer Research · 2025
  not yet assessed
• IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas ↗

  Science Advances · 2025 · PMID 40880486
  not yet assessed
• Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers ↗

  Nature Communications · 2024 · PMID 38877018
  not yet assessed
• Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers ↗

  Research Square · 2024 · PMID 38313284
  not yet assessed
• Abstract 403: APOBEC3 enzymes induce chromosomal translocations in solid cancer ↗

  Cancer Research · 2024
  not yet assessed
• Distinct and Overlapping Patterns of Chromosomal Translocations Induced by AID and APOBEC3 Family Proteins in Cancer ↗

  SSRN Electronic Journal · 2024
  not yet assessed
• ERα-associated translocations underlie oncogene amplifications in breast cancer ↗

  Nature · 2023 · PMID 37198482
  not yet assessed
• ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer ↗

  Nature Cancer · 2023 · PMID 37430060
  not yet assessed
• Abstract 313: Mechanisms of oncogenic tyrosine kinase fusion formation and selection in human cancers ↗

  Cancer Research · 2023
  not yet assessed
• Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy ↗

  Neuron · 2022 · PMID 36070751
  not yet assessed
• Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma ↗

  Blood · 2021 · PMID 34657149
  not yet assessed
• Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma ↗

  Blood Advances · 2021 · PMID 34625792
  not yet assessed
• Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. ↗

  Apollo (University of Cambridge) · 2021
  not yet assessed
• Assessment of Cellular Uptake Efficiency According to Multiple Inhibitors of Fe3O4-Au Core-Shell Nanoparticles: Possibility to Control Specific Endocytosis in Colorectal Cancer Cells ↗

  Nanoscale Research Letters · 2020 · PMID 32804261
  not yet assessed
• Abstract 2400: Strong biological bias for ALK intron 19 breakpoints in NSCLC ↗

  Cancer Research · 2020
  not yet assessed
• Abstract 2393: APOBEC3 enzymes induce chromosomal translocations in solid cancers ↗

  Cancer Research · 2020
  not yet assessed
• Abstract PO-50: Phophatases modulate resistance to ALK inhibitors in anaplastic large-cell lymphoma ↗

  Blood Cancer Discovery · 2020
  not yet assessed
• CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation

  Cell Reports · 2019 · PMID 31365872
  L1 No data access
• Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity ↗

  The Journal of Physical Chemistry B · 2019 · PMID 31310131
  not yet assessed
• Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma ↗

  Blood · 2019
  not yet assessed
• CRISPR/Cas9 Screens Reveal Multiple Layers of B Cell CD40 Regulation ↗

  SSRN Electronic Journal · 2019
  not yet assessed
• Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice ↗

  Frontiers in Immunology · 2018 · PMID 30279688
  not yet assessed
• Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma ↗

  Nature Medicine · 2018 · PMID 30510251
  not yet assessed
• The CRISPR/Cas9 System as a Tool to Engineer Chromosomal Translocation In Vivo ↗

  Advances in experimental medicine and biology · 2018 · PMID 29956290
  not yet assessed
• Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells ↗

  Nature · 2017 · PMID 28199309
  not yet assessed
• FBXO11 Is Recurrently Mutated in Burkitt Lymphoma and Its Inactivation Accelerates Lymphomagenesis in Eμ-Myc mice ↗

  Blood · 2017
  not yet assessed
• Abstract PR10: FBXO11 is recurrently mutated in Burkitt lymphoma and its inactivation accelerates lymphomagenesis in Eμ-myc mice ↗

  Clinical Cancer Research · 2017
  not yet assessed
• Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system ↗

  Nature Communications · 2016 · PMID 26956543
  not yet assessed
• PI3Kdelta Inhibitors Increase Genomic Instability By Upregulating Aid Expression ↗

  Blood · 2015
  not yet assessed
• FBXO11, a Regulator of BCL6 Stability, Is Recurrently Mutated in Burkitt Lymphoma ↗

  Blood · 2015
  not yet assessed
• Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology ↗

  Cell Reports · 2014 · PMID 25456124
  not yet assessed
• Synthesis of Multifunctional Fe₃O₄–CdSe/ZnS Nanoclusters Coated with Lipid A toward Dendritic Cell-Based Immunotherapy ↗

  ACS Applied Materials & Interfaces · 2014 · PMID 24641174
  not yet assessed
• Functional Manipulation of Dendritic Cells by Photoswitchable Generation of Intracellular Reactive Oxygen Species ↗

  ACS Chemical Biology · 2014 · PMID 25458073
  not yet assessed
• Orientia tsutsugamushi Subverts Dendritic Cell Functions by Escaping from Autophagy and Impairing Their Migration ↗

  PLoS neglected tropical diseases · 2013 · PMID 23301113
  not yet assessed
• A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy ↗

  Nature Nanotechnology · 2011 · PMID 21909083
  not yet assessed
• Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer ↗

  Clinical & Experimental Metastasis · 2011 · PMID 21750908
  not yet assessed
• Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents ↗

  Cancer Science · 2009 · PMID 19843071
  not yet assessed
• Rapamycin, mTOR inhibitor, a potent inhibitor for the cell growth and proliferation by p21- dependent mitotic arrest in human gastric cancers

  Cancer Research · 2008
  not yet assessed
• Nucleotide Sequence and Expression of a Gentamicin Resistance Gene Isolated from the R Plasmid in Serratia marcescens ↗

  Biochemical and Biophysical Research Communications · 1994 · PMID 8117265
  not yet assessed